P3 Health Partners Inc.
PIII · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,500,455 | $1,266,375 | $1,049,471 | $637,365 |
| % Growth | 18.5% | 20.7% | 64.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $668,066 |
| Gross Profit | $1,500,455 | $1,266,375 | $1,049,471 | -$30,701 |
| % Margin | 100% | 100% | 100% | -4.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $112,596 | $122,362 | $157,284 | $0 |
| SG&A Expenses | $113,927 | $125,595 | $162,380 | $157,244 |
| Sales & Mktg Exp. | $1,331 | $3,233 | $5,096 | $0 |
| Other Operating Expenses | $1,707,186 | $1,308,710 | $2,448,004 | $0 |
| Operating Expenses | $1,821,113 | $1,434,305 | $2,610,384 | $157,244 |
| Operating Income | -$320,658 | -$167,930 | -$1,560,913 | -$187,945 |
| % Margin | -21.4% | -13.3% | -148.7% | -29.5% |
| Other Income/Exp. Net | $14,667 | -$15,801 | $1,218 | -$16,393 |
| Pre-Tax Income | -$305,991 | -$183,731 | -$1,559,695 | -$204,338 |
| Tax Expense | $4,387 | $2,695 | $1,862 | $0 |
| Net Income | -$135,849 | -$57,773 | -$270,127 | -$156,481 |
| % Margin | -9.1% | -4.6% | -25.7% | -24.6% |
| EPS | -46.79 | -30.443 | -324.836 | -188.174 |
| % Growth | -53.7% | 90.6% | -72.6% | – |
| EPS Diluted | -54.06 | -30.443 | -324.836 | -188.174 |
| Weighted Avg Shares Out | 2,904 | 1,898 | 832 | 832 |
| Weighted Avg Shares Out Dil | 2,940 | 1,898 | 832 | 832 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $22,173 | $15,985 | $11,404 | $10,675 |
| Depreciation & Amortization | $86,058 | $86,675 | $87,289 | $8,724 |
| EBITDA | -$197,760 | -$81,071 | -$1,461,002 | -$184,615 |
| % Margin | -13.2% | -6.4% | -139.2% | -29% |